Literature DB >> 12352369

Optimal timing of initial postnatal ultrasonography in newborns with prenatal hydronephrosis.

John S Wiener1, Sara M O'Hara.   

Abstract

PURPOSE: Conflicting data exist concerning optimal timing for initial postnatal ultrasound in newborns with prenatal hydronephrosis. To determine whether timing significantly affects the accuracy of postnatal ultrasound, we conducted a prospective study comparing ultrasound within 48 hours of birth and at 7 to 10 days of life.
MATERIALS AND METHODS: A total of 21 consecutive newborns with prenatal hydronephrosis were enrolled in 14 months. Prenatal hydronephrosis was defined as a pelvic diameter 4 mm. or greater before 33 weeks and 8 mm. or greater beginning at 33 weeks of gestation. Postnatal hydronephrosis was assessed using the Society for Fetal Urology grading system. Patients were subsequently followed with serial ultrasound and adjunctive imaging studies.
RESULTS: Of the 32 evaluable renal units a majority had a change in the degree of hydronephrosis between the first and second ultrasound. An increase in hydronephrosis was found in 14 (44%) renal units with an increase of 2 or greater grades in 8 (25%). At a median followup of 15 months only 3 renal units had a persistent increase in hydronephrosis. None had greater than grade 2 hydronephrosis or required therapeutic intervention. A decrease in hydronephrosis between the first and second ultrasound was noted in 8 (25%) renal units. Seven renal units were excluded from analysis due to unequivocal obstruction, and none of these demonstrated a change between the 2 sonograms.
CONCLUSIONS: The degree of hydronephrosis varied between scans performed in the first 48 hours and 7 to 10 days of life in most newborns. The initial ultrasound more commonly underestimated the degree of hydronephrosis but this difference was not clinically significant at further followup. We recommend initial postnatal sonogram at 7 to 10 days of life for routine prenatal hydronephrosis but earlier scans may be appropriate in select cases.

Entities:  

Mesh:

Year:  2002        PMID: 12352369     DOI: 10.1097/01.ju.0000030859.88692.dd

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

Review 1.  Management of fetal hydronephrosis.

Authors:  Jenny Yiee; Duncan Wilcox
Journal:  Pediatr Nephrol       Date:  2007-08-02       Impact factor: 3.714

2.  Antenatal and postnatal ultrasound in the evaluation of the risk of vesicoureteral reflux.

Authors:  Serge Grazioli; Paloma Parvex; Laura Merlini; Christophe Combescure; Eric Girardin
Journal:  Pediatr Nephrol       Date:  2010-06-04       Impact factor: 3.714

Review 3.  Prenatal hydronephrosis: postnatal evaluation and management.

Authors:  Vijaya Vemulakonda; Jenny Yiee; Duncan T Wilcox
Journal:  Curr Urol Rep       Date:  2014-08       Impact factor: 3.092

4.  Clinical importance of pyelocalyceal dilation diagnosed by postnatal ultrasonographic screening of the urinary tract.

Authors:  Kristina Drnasin; Mirna Saraga-Babić; Marijan Saraga
Journal:  Med Sci Monit       Date:  2013-02-19

5.  Determination of the Need for Surgical Intervention in Infants Diagnosed with Fetal Hydronephrosis in China.

Authors:  Lei Zhang; Chao Liu; Yan Li; Chao Sun; Xiang Li
Journal:  Med Sci Monit       Date:  2016-11-06

Review 6.  Ultrasonography of hydronephrosis in the newborn: a practical review.

Authors:  Young Hun Choi; Jung-Eun Cheon; Woo Sun Kim; In-One Kim
Journal:  Ultrasonography       Date:  2016-03-30

7.  Incidence and outcomes of antenatally detected congenital hydronephrosis.

Authors:  Jameela Abdulaziz Kari; Saddiq Habiballah; Saad A Alsaedi; Hussain Alsaggaf; Amal Al-dabbagh; Adila AbulHamail; Adel Marzouki; Basem Eldeek
Journal:  Ann Saudi Med       Date:  2013 May-Jun       Impact factor: 1.526

8.  Revised guidelines on management of antenatal hydronephrosis.

Authors:  A Sinha; A Bagga; A Krishna; M Bajpai; M Srinivas; R Uppal; I Agarwal
Journal:  Indian J Nephrol       Date:  2013-03

9.  Evaluation of TGF-β1, CCL5/RANTES and sFas/Apo-1 urine concentration in children with ureteropelvic junction obstruction.

Authors:  Aleksandra Gawłowska-Marciniak; Jerzy K Niedzielski
Journal:  Arch Med Sci       Date:  2013-08-08       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.